If doctors are currently using the technique, the new results "should give them pause," said Dr. Suresh Boppana, a professor of pediatric infectious diseases at the University of Alabama at Birmingham. And with the treatment appearing to cause more adverse effects, "one has to be somewhat more careful."
Several U.S. cardiologists also called for a refocusing on the biology behind renal denervation to find out why the benefits demonstrated in animal models have not been translated into humans. Suzanne Oparil, MD, a hypertension specialist at the University of Alabama at Birmingham, was involved in some of that early research and told MedPage Today that she was optimistic that the approach would work.
oday, we share answers from a survey conducted with the 40 Bizwomen participants from Alesia Jones, chief human resources officer at the University of Alabama at Birmingham, the state's largest employer with about 18,000 employees. Jones has served in this top role since 2009.